The New York State Senate has unanimously passed Senate Bill S. 2000, a significant step toward improving the early detection ...

Lung cancer is one of the most challenging diseases, making early diagnosis crucial for effective treatment. Fortunately, ...

Silicosis is an incurable but entirely preventable lung disease. It has only one cause: breathing in too much silica dust.

The silicosis research gained backing from the iCare Dust Diseases Board via a Discovery and Innovation grant.

Electrical engineer Mounya Elhilali relies on federal funding to push the boundaries of how technology can enhance human ...

Zydus Lifesciences Ltd. on Tuesday said it has entered into exclusive negotiations to acquire a majority stake in France-based Amplitude Surgical for €256.8 million. “The acquisition price ...

Stocks to watch Zydus Life: The pharma company, formerly known as Cadila Healthcare, to acquire french orthopedics firm Amplitude Surgical for ₹2,851 crore. Amplitude Surgical is engaged in design, ...

Sharvil Patel, Managing Director, Zydus Lifesciences Ltd. (Image Credits: FE.com) Zydus Lifesciences on Tuesday announced that it will be acquiring 85.6 percent stake in France-based Amplitude ...

Zydus Lifesciences on Tuesday said it has entered into exclusive negotiations to acquire a majority stake in France-based Amplitude Surgical for 256.8 million euros (nearly $280 million). The company ...

Zydus Lifesciences Limited on Tuesday announced that the company has entered into exclusive negotiations to acquire majority Amplitude Surgical. Purchase consideration amounts to €256.8mn for 85 ...

Zydus Lifesciences will acquire a majority stake in Amplitude Surgical, a European MedTech leader in lower-limb orthopaedic technologies, for €256.8 million. The acquisition will expand Zydus's ...

"This validation study is expected to be completed this year; if the findings align with previous results, the Nu.Q® test may be considered for use in combination with any national lung cancer ...